Inventor · disambiguated record
Bingwei Yang
Also filed as: YANG BINGWEI V · YANG BINGWEI VERA · YANG Bingwei
45 granted patents·7 pending applications·745 citations·filing 1992–2023
98Inventor score
Files withPFIZER23BRISTOL MYERS SQUIBB CO13CHENGDU BOE OPTOELECT TECH CO3WROBLESKI STEPHEN T3BOE TECHNOLOGY GROUP CO LTD2
Top patents by PatentIndex Score
52 records- 0197US6586447B13,3-disubstituted-oxindole derivatives useful as anticancer agentsPFIZER·Filed 2000·Granted Jul 1, 2003·77 cites·21 claims
- 0296US6258824B1Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agentsPFIZER·Filed 2000·Granted Jul 10, 2001·87 cites·32 claims
- 0390US6596735B1Quinoline derivatives useful for inhibiting farnesyl protein transferasePFIZER·Filed 2000·Granted Jul 22, 2003·41 cites·15 claims
- 0489US6777393B24″-substituted-9-deoxo-9a-aza-9a homoerythromycin a derivativePFIZER·Filed 2002·Granted Aug 17, 2004·28 cites·8 claims
- 0589US6479513B2Anticancer compound and enantiomer separation method useful for synthesizing said compoundPFIZER·Filed 2001·Granted Nov 12, 2002·31 cites·8 claims
- 0688US7273881B2Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Sep 25, 2007·7 cites·12 claims
- 0788US6388092B2Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agentsPFIZER·Filed 2001·Granted May 14, 2002·27 cites·2 claims
- 0888US5441939A3"-desmethoxy derivatives of erythromycin and azithromycinPFIZER·Filed 1994·Granted Aug 15, 1995·71 cites·11 claims
- 0987US7317024B2Heterocyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jan 8, 2008·10 cites·11 claims
- 1086US6844357B2Substituted quinolin-2-one derivatives useful as antiproliferative agentsPFIZER·Filed 2001·Granted Jan 18, 2005·18 cites·11 claims
- 1186US6025350AC-4" substituted macrolide antibioticsPFIZER·Filed 1998·Granted Feb 15, 2000·36 cites·10 claims
- 1285US6995181B2Modulators of the glucocorticoid receptor and methodBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Feb 7, 2006·23 cites·28 claims
- 1384US7326728B2Modulators of glucocorticoid receptor, AP-1, and/or NF-κβ activity and use thereofBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Feb 5, 2008·4 cites·13 claims
- 1484US7253283B2Tricyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Aug 7, 2007·6 cites·15 claims
- 1582US7411071B2Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Aug 12, 2008·6 cites·7 claims
- 1682US6964961B2Thiophene derivatives useful as anticancer agentsPFIZER·Filed 2001·Granted Nov 15, 2005·17 cites·21 claims
- 1782US6710209B2Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agentsPFIZER·Filed 2002·Granted Mar 23, 2004·13 cites·1 claims
- 1880US8034940B2Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Oct 11, 2011·4 cites·11 claims
- 1979US6194438B1Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one, and compositions and methods for inhibiting abnormal cell growth comprising said derivativesPFIZER·Filed 1999·Granted Feb 27, 2001·46 cites·10 claims
- 2077US6407074B1C-4″-substituted macrolide derivativesPFIZER·Filed 1998·Granted Jun 18, 2002·43 cites·27 claims
- 2174US6576749B2C-4″-substituted macrolide derivativesPFIZER·Filed 2002·Granted Jun 10, 2003·5 cites·4 claims
- 2274US6495564B1Quinolin-2-one derivatives useful as anticancer agentsPFIZER·Filed 1999·Granted Dec 17, 2002·37 cites·26 claims
- 2374US6080769AImidazolidin-4-one derivatives useful as anticancer agentsPFIZER·Filed 1998·Granted Jun 27, 2000·34 cites·9 claims
- 2471US11127347B2Pixel circuit, driving method thereof and display panelBOE TECHNOLOGY GROUP CO LTD·Filed 2019·Granted Sep 21, 2021·1 cites·17 claims
- 2571US5686587AIntermediate for azithromycinPFIZER·Filed 1994·Granted Nov 11, 1997·22 cites·11 claims
- 2670US8987268B2Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseasesWROBLESKI STEPHEN T·Filed 2012·Granted Mar 24, 2015·2 cites·14 claims
- 2770US6300316B1C-4 substituted macrolide antibioticsPFIZER·Filed 1999·Granted Oct 9, 2001·25 cites·11 claims
- 2866US8013004B2Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Sep 6, 2011·0 cites·6 claims
- 2964US9221826B2Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseasesWROBLESKI STEPHEN T·Filed 2012·Granted Dec 29, 2015·1 cites·10 claims
- 3059US6420536B14″-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivativesPFIZER·Filed 1998·Granted Jul 16, 2002·11 cites·12 claims
- 3156US7642273B2Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jan 5, 2010·0 cites·4 claims
- 3256US7544808B2Tricyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Jun 9, 2009·0 cites·14 claims
- 3355US8106046B2Cyclopentathiophene modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofYANG BINGWEI VERA·Filed 2009·Granted Jan 31, 2012·0 cites·10 claims
- 3455US2025126978A1Display baseplate and display panelCHENGDU BOE OPTOELECT TECH CO·Filed 2023·Application pending·0 cites
- 3554US2025126970A1Light-Emitting Device, Display Panel and Display ApparatusCHENGDU BOE OPTOELECT TECH CO·Filed 2023·Application pending·0 cites
- 3654US2025234751A1Display substrate and display deviceBOE TECHNOLOGY GROUP CO LTD·Filed 2023·Application pending·0 cites
- 3753US2025241181A1Display substrate and display deviceCHENGDU BOE OPTOELECT TECH CO·Filed 2023·Application pending·0 cites
- 3852US2002061858A14"-substituted-9-deoxo-9A-AZA-9A-homoerythromycin a derivativesFiled 2001·Application pending·0 cites
- 3950US5985912A4-hydroxy coumarin derivativesPFIZER·Filed 1998·Granted Nov 16, 1999·5 cites·6 claims
- 4049US12219796B2Display substrate having a blocking dam provided with at least one groove and manufacturing method therefor, and display deviceMIANYANG BOE OPTOELECTRONICS TECH CO LTD·Filed 2020·Granted Feb 4, 2025·0 cites·12 claims
- 4149US2005171136A1Modulators of the glucocorticoid receptor and methodFiled 2005·Application pending·0 cites
- 4248US7968577B2Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Jun 28, 2011·0 cites·16 claims
- 4347US11132951B2Pixel circuit, pixel driving method and display deviceMIANYANG BOE OPTOELECTRONICS TECH CO LTD·Filed 2019·Granted Sep 28, 2021·0 cites·20 claims
- 4444US8198311B2Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofSHEPPECK JAMES E·Filed 2007·Granted Jun 12, 2012·0 cites·9 claims
- 4543US7361654B2Substituted heteroaryl amide modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Apr 22, 2008·0 cites·14 claims
- 4642US9428511B2Imidazopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseasesBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Aug 30, 2016·0 cites·13 claims
- 4742US8222247B2Modulators of glucocorticoid receptor, AP-1, and/or NF-kappabeta activity and use thereofYANG BINGWEI VERA·Filed 2007·Granted Jul 17, 2012·0 cites·14 claims
- 4840US5407943AAzaspiro quinolone antibacterial agentsPFIZER·Filed 1992·Granted Apr 18, 1995·3 cites·9 claims
- 4939US6174903B1Imidazolidin-4-one derivatives useful as anticancer agentsPFIZER·Filed 1999·Granted Jan 16, 2001·1 cites·14 claims
- 5039US2002004511A1Thiophene derivatives useful as anticancer agentsFiled 2001·Application pending·0 cites
Showing the top 50 of 52 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →